EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Prospective, Randomized, Controlled Trial of Methylene Blue Injection for Costal Cartilage Harvest Postoperative Analgesia

Ziang Zhang iD, Ziyu Zhu, Hengxin Liu iD, Jie Chen, Changxin Jin, Xi Zhang iD

Aesthetic Surgery Journal · 2025

DOI: 10.1093/asj/sjae203 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Surgery Journal, 2025. Verfasst von Ziang Zhang und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Methylene Blue, Postoperative Pain, Costal Cartilage, Tissue and Organ Harvesting. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Air Force Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In plastic surgery, costal cartilage is an excellent support material. However, postoperative pain from costal cartilage harvesting can impact patient recovery and satisfaction with the surgery. Recent reports have shown that methylene blue (MB) is an effective local analgesic in postoperative management.

Objectives

We aimed to evaluate the safety and effectiveness of MB for pain relief in patients undergoing costal cartilage harvesting.

Methods

A total of 106 patients undergoing costal cartilage harvesting surgery were selected from the plastic surgery department between December 2022 and March 2024. They were randomly divided into 2 groups: the MB group and the ropivacaine group, with 53 patients in each group. Pain levels were assessed with a numerical rating scale, the Insomnia Severity Index (ISI), arm elevation angle, and postoperative satisfaction scales at 1 day, 3 days, 5 days, 1 week, 1 month, and 3 months postoperatively.

Results

Patients receiving MB exhibited a significant decrease in pain scores from 5 days to 1 month of treatment compared to the ropivacaine group. Additionally, in the MB group there was an improvement in ISI scores from 5 days to 1 month compared to the ropivacaine group. Furthermore, during the 3-month follow-up, the MB group had significant increases in satisfaction scores compared to the control group. Arm elevation angle in the MB group was significantly higher compared to the ropivacaine group at 5 days, 1week, and 1month. No serious adverse events were reported, with only 2 patients experiencing an allergic rash.

Conclusions

Methylene blue demonstrated significant pain reduction with minimal adverse effects. Level of Evidence: 3 (Therapeutic)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methylene BluePostoperative PainCostal CartilageTissue and Organ HarvestingHumansFemaleMaleAdultProspective StudiesMiddle AgedRopivacainePain MeasurementPatient SatisfactionTreatment OutcomeAnesthetics, LocalYoung AdultInjections

Substanzen

Methylene BlueRopivacaineAnesthetics, Local

Autor:innen und Institutionen

ORCID-Profile: Ziang Zhang, Hengxin Liu, Xi Zhang

Förderung

  • National Natural Science Foundation of China
  • Air Force Medical University

Zitieren

APA

Zhang, Z., Zhu, Z., Liu, H., Chen, J., Jin, C., & Zhang, X. (2025). A Prospective, Randomized, Controlled Trial of Methylene Blue Injection for Costal Cartilage Harvest Postoperative Analgesia. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjae203

Vancouver

Zhang Z, Zhu Z, Liu H, Chen J, Jin C, Zhang X. A Prospective, Randomized, Controlled Trial of Methylene Blue Injection for Costal Cartilage Harvest Postoperative Analgesia. Aesthetic Surgery Journal. 2025. doi:10.1093/asj/sjae203

BibTeX
@article{Zhang2025,
  author = {Zhang, Ziang and Zhu, Ziyu and Liu, Hengxin and Chen, Jie and Jin, Changxin and Zhang, Xi},
  title = {A Prospective, Randomized, Controlled Trial of Methylene Blue Injection for Costal Cartilage Harvest Postoperative Analgesia},
  journal = {Aesthetic Surgery Journal},
  year = {2025},
  doi = {10.1093/asj/sjae203}
}
Kostenlos starten →